Piperonal
CAS 120-57-0
Piperonal (CAS 120-57-0) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 2816923.076923077 nM | 13 | - |
| - | Potency | 18918.166666666668 nM | 3 | - |
| - | EC50 | 44 ug.mL-1 | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| HELIOTROPINE | 33753 | SU | MTHSPL |
| PIPERONAL | 33753 | SU | MTHSPL |
| piperonal | 33753 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Piperonal used for in pharmaceutical contexts?
Piperonal (CAS 120-57-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Piperonal?
No adverse-event association or SIDER side-effect rows are rendered for Piperonal in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Piperonal also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Heliotropine with EU status "restricted".
What clinical phase is Piperonal in?
No phase 1-4 clinical development badge is rendered for Piperonal because the matched compound identifier rows do not contain a max-phase value.